A big difference between now and March is that we have now had 2 successive Qs showing that convertible debt is virtually eliminated. The problem that existed in 2016 has been corrected. The challenges now are basic business challenges (selling and scaling), not OTC headaches like dilution.
Products to sell. Data to sell. It's a good time to take a look at what the company offers. Strong future imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.